Evidence map

ReviewDrug discovery today2021

Myotonic dystrophy type 1 drug development: A pipeline toward the market.

Marta Pascual-Gilabert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

28 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33798646